Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ONCOKINE-1 is a soluble protein secreted by tumor cells that promotes resistance to cancer immunotherapies and contributes to tumor progression by modulating the tumor microenvironment. It suppresses tumor cell apoptosis and inhibits dendritic cell activation, leading to an immunosuppressive "immune-cold" environment.
Neutralization of ONCOKINE-1, blocking its interaction with target cells in the tumor microenvironment.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ONCOKINE-1 (OK-1).